APIs

Our Products

API Therapeutic segment
  • Albuterol / Salbutanol Sulphate Anti – Asthmatic
  • Alcaftadine Conjuctives
  • Aripiprazole CNS
  • Asenapine Maleate Schizophrenia
  • Bosentan Monohydrate Vasodilator
  • Ciprofloxacin Base Fluoroquinolones
  • Ciprofloxacin Hydrochloride Fluoroquinolones
  • Dabigatran Etexilate Mesylate CVS
  • Darifenacin HydroBromide Anti – Spasmodic
  • Deferasirox Iron Chelator
  • Donepezil HCL Form – I CNS
  • Enalapril Maleate Cardiovascular
  • Entacapone Form A CNS
  • Escitalopram Oxalate CNS
  • Ezetimibe Cardiovascular
  • Indacaterol Chronic Obstructive Pulmonary Disease
  • Ipratropium Bromide Anti – Asthmatic
  • Itraconazole Powder Anti – Fungal
  • Lacosamide CNS
  • Leuprolide Antineoplastic Agent / Gonadorelin Agonist
  • Levetiracetam CNS
  • Levofloxacin Hemihydrate Fluoroquinolones
  • Linezolid Form-II Anti – Bacterial
  • Lurasidone Anti – Psychotic Agent
  • Mirtazapine CNS
  • Montelukast Sodium Anti – Asthmatic
  • Moxifloxacin Hydrochloride Fluoroquinolones
  • Moxonidine Anti - Hypertensive
  • Ofloxacin Fluroquinolones
  • Olanzapine Form – I CNS
  • Paliperidone Base Anti – Psychotic Agent
  • Paliperidone Palmitate Anti – Psychotic Agent
  • Posaconazole Form 1 Anti - Fungal
  • Propofol Anesthetic
  • Ramipril Cardiovascular
  • Ranitidine Hydrochloride (Form -  II) Anti-Ulcerant
  • Ropinirole Base CNS
  • Ropinirole Hydrochloride CNS
  • Salmeterol Xinafoate Anti – Asthmatic
  • Saxagliptin Anti-Diabetic
  • Sotalol Hydrochloride Cardiovascular
  • Sugammadex Reversal agent for Neuro-muscular Blocking
  • Vilazodone Antidepressant
  • Voriconazole* Anti – Fungal

* Filed

DMFs are available on request.
Above list represents our existing and pipeline products wherein, some products are still covered under valid Indian Patents and are not available for immediate commercial supply. Those products which are presently covered under valid Indian Patents will be available for commercial supply only after expiry of the respective Patents in India. Products covered by valid patents in any country, are not offered or supplied to those countries.




Feedback